Schedule 13G ownership disclosure

Mirati Therapeutics Inc

Security class unavailable · CUSIP: 60468T105

Event date: 2016-08-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.0200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-16-014509
Form type
SC 13G
Filer
Broadfin Capital, LLC
CIK
CIK 1511901
Filed
Aug 10, 2016
Reporting period
Aug 08, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub